• Power Peptide UK research vial
1 1

Tesamorelin

Tesamorelin

£110.00 GBP
£110.00 GBP
Sale Sold out
Taxes included.
Size

Stabilised GHRH analogue studied in visceral adipose research.

Overview

Tesamorelin is a stabilised synthetic analogue of growth hormone-releasing hormone (GHRH), modified with a trans-3-hexenoyl group at the N-terminus to resist enzymatic degradation.

Research applications

  • GHRH receptor agonism at the pituitary
  • Endogenous, pulsatile GH release
  • Visceral adipose tissue in research models
  • IGF-1 response studies
  • Lipid profile and triglyceride markers

Mechanism of action

Binds GHRH receptors on pituitary somatotrophs, stimulating the release of the body's own growth hormone in a pulsatile pattern rather than supplying exogenous GH. The N-terminal modification markedly extends half-life against DPP-4 cleavage.

Specifications

Molecular weight 5,135.9 Da
Purity ≥98% (HPLC)
Form Lyophilised powder
Storage −20°C
Reconstitution Bacteriostatic water
Origin UK
Research use only. Supplied strictly for in-vitro laboratory research. Not for human or animal consumption, and not for diagnostic or therapeutic use. To be handled only by qualified professionals. You must be 18 or over to purchase. Certificate of analysis available for every batch on request.
View full details